Mohammad Tariq Malik

Title: Innovations of Mohammad Tariq Malik

Introduction

Mohammad Tariq Malik is an accomplished inventor based in Prospect, Kentucky, known for his significant contributions to the field of nanotechnology and cancer treatment. With a total of four patents to his name, he has made strides in developing innovative solutions that enhance the effectiveness of cancer therapies.

Latest Patents

Among his latest patents, Malik has developed anti-nucleolin agent-conjugated nanoparticles. This composition comprises an anti-nucleolin agent conjugated to nanoparticles that are non-magnetic, not iron oxide, and not polyacrylamide. Additionally, he has created a pharmaceutical composition for treating cancer that includes this anti-nucleolin agent conjugated to nanoparticles along with a pharmaceutically acceptable carrier. Another notable patent involves anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agents. This composition also includes gadolinium and enhances the effectiveness of radiation therapy while improving contrast in X-ray imaging techniques. When gadolinium is present, it provides cancer-selective MRI contrast agents.

Career Highlights

Malik is affiliated with the University of Louisville Research Foundation, Inc., where he continues to advance his research and innovations. His work focuses on the intersection of nanotechnology and oncology, aiming to improve treatment outcomes for cancer patients.

Collaborations

Some of his notable coworkers include Paula J Bates and Kyung Aih Kang, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Mohammad Tariq Malik's innovative work in developing anti-nucleolin agent-conjugated nanoparticles represents a significant advancement in cancer treatment technologies. His contributions are paving the way for more effective therapies and improved patient outcomes.